|Videos|June 11, 2021
CDMOs: Embracing Change and a Look Toward the Future
Author(s)AMRI
John Ratliff entered the contract research, development and manufacturing (CDMO) industry at the end of 2019, just months before the COVID-19 pandemic emerged. As a veteran of the information technology and clinical research (CRO) industries, he is accustomed to leading through dramatic change. Here, John discusses his approach to leading through periods of uncertainty and shares how AMRI has embraced change, staying relevant to its customers while preparing to celebrate its 30-year anniversary. Topics of discussion include:
· How the COVID-19 pandemic meets an industry in the midst of change
· Leading through transformational change
· Industry and AMRI’s evolution over the course of 30 years
Related Content
Trending on Pharmaceutical Technology
1
What the Ocrelizumab Deal Does for the Multiple Sclerosis Biosimilar Pipeline
2
The Next Generation of Medicine: Personalized, Preventive, and Powered by Technology
3
The Implications of Isatuximab-irfc’s FDA Approval for Multiple Myeloma
4
What FDA's AI Warning Letter Tells Us About GMP Accountability
5